Liability risks emerge as an obstacle in Europe's COVID-19 vaccine negotiations
With all eyes on the hunt for COVID-19 vaccines, Europe’s supply negotiations with drugmakers have hit snags over potential liability for side effects, Reuters reports.
While some companies are in "advanced discussions" to supply tens or hundreds of millions of doses to European countries, only AstraZeneca has completed an agreement—for 400 million doses.
That deal provides AstraZeneca some protection, according to the news service. It "foresees that liabilities and financial costs are shared among the parties,” Belgium's medicines agency told Reuters. AstraZeneca has agreed to provide doses at no profit during the pandemic.
Meanwhile, Johnson & Johnson, Sanofi and GSK, CureVac and Moderna are in “advanced” discussions to supply doses if their candidates succeed. But those deals haven't yet been finalized, and liability risks could play into the talks.
You May Interested In
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Which Companies Are Making Covid Vaccines
-
The Indian Variant Vaccine Efficacy is only 10%, and it was abandoned by South Africa
-
Compensation Methods For Adverse Reactions To Vaccines In The Post-Epidemic Period
-
The Johnson & Johnson Vaccine Is Only 72% Effective, Is It An Inferior Vaccine?
-
Research On The Distribution Of The Incubation Period Of COVID-19
-
How Many Covid Vaccines Are Made Per Second?
-
Protein Based Vaccines Examples : The Second Generation Of The COVID-19 Vaccine Is Coming
-
Does Vaccine Protect Against Omicron? Zhang Wenhong : Vaccination Booster Is Still An Effective Tool To Deal With Omicron
-
Are Covid Vaccines Patented ?
-
Several Domestic New Crown Mrna Companies Turn To Developing Broad-Spectrum Vaccines, Exploring Against Different Mutant Strains
Recommend Reading
-
![China’s Chemical “Spring Surge”: 68.8% of Products Rising—Real Recovery or Just a Pre-Festival Mirage?]()
China’s Chemical “Spring Surge”: 68.8% of Products Rising—Real Recovery or Just a Pre-Festival Mirage?
-
![Steel in the Hourglass: Germany’s “Protect-Steel” Proposal and the Green Calculation Behind It]()
Steel in the Hourglass: Germany’s “Protect-Steel” Proposal and the Green Calculation Behind It
-
![Geno and Sojitz Collaborate to Accelerate the Commercialization of Nylon 6]()
Geno and Sojitz Collaborate to Accelerate the Commercialization of Nylon 6
-
![BASF's Zhanjiang Integrated Site Reaches Major Milestone: Butyl Acrylate Production Commences Ahead of Schedule, Steam Cracker Completes Mechanical Completion]()
BASF's Zhanjiang Integrated Site Reaches Major Milestone: Butyl Acrylate Production Commences Ahead of Schedule, Steam Cracker Completes Mechanical Completion
-
![China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain]()
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
-
![This week, the domestic propylene oxide market showed a narrow fluctuation with weak transactions (May 18-22)]()
This week, the domestic propylene oxide market showed a narrow fluctuation with weak transactions (May 18-22)
-
![This Week Aniline Market Weakens in China (5.18-5.22)]()
This Week Aniline Market Weakens in China (5.18-5.22)
-
![Multiple Factors Combine to Drive a Sharp Correction in Ethylene Oxide Prices in May]()
Multiple Factors Combine to Drive a Sharp Correction in Ethylene Oxide Prices in May
-
![In-depth Analysis of the Reasons for the Decrease in Ethylene Glycol Prices on May 22, 2026 in China]()
In-depth Analysis of the Reasons for the Decrease in Ethylene Glycol Prices on May 22, 2026 in China
-
![Widening Downward Spread, Weekly Decline in n-Butanol Exceeds 5%]()
Widening Downward Spread, Weekly Decline in n-Butanol Exceeds 5%
